Skip to content

The effect of sodium concentration in the maintenance intravenous fluid therapy on iatrogenic hyponatremia of children with acute illness : a randomized controlled trial

The effect of sodium concentration in the maintenance intravenous fluid therapy on iatrogenic hyponatremia of children with acute illness : a randomized controlled trial - NaMIH

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006942
Enrollment
2560
Registered
2011-12-28
Start date
2011-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute illness in children

Interventions

Group A : Hypotonic fluids(Na 35mEq/l) determined by the volumetirc Holliday-Segar formula. Group B : Relatively hypertonic fluids(Na 68mEq/l : adding 10ml of 10% saline to 500ml of Group A&#39
s fluids ) at 80% of the Group A&#39
s rate.

Sponsors

National Hospital Organization Okayama Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients hospitalized with acute illness 2. Judged by the treating physician to require i.v. maintenance fluid administration for at least the following 24 h 3. A necessary clinical examination for dehydraion is confirmed before starting initial rehydraion therapy 4. Patient during or before initial rehydration therapy using normal saline or Ringer's solution(10-20ml/kg) 5. Age over 3months and under 10 years 6. Judged by the treating physician to have adequate liver/renal/cardiac function 7. Written informed concent must be obtained for the study from the parent or guardian

Exclusion criteria

Exclusion criteria: 1. Patients with serum Na <130 or >150, serum K <3.2 or >5.5 2. Patients with clinical condition lilely to develop electrolyte abnormality 3. Treatment which affect the serum sodium value is planned 4. Patients who require drugs insoluble in allocated fluids during the study period 5. Any other cases who are regarded as inadequate for study enrollment by the investigator

Design outcomes

Primary

MeasureTime frame
The incidence of hyponatremia after maintenance intravenous fluid therapy

Secondary

MeasureTime frame
(1) Severiy of hyponatremia, clinical presentation associated with hyponatremia, with or without any other complication (2) Change of serum sodium value between before and after maintenance intravenous fluid therapy (3) Patient background-specific difference of incidence of hyponatremia (4) Discontinuation rate of maintenance intravenous fluid therapy due to side effect (5) Safety profile

Countries

Japan

Contacts

Public ContactJunya Shimizu

National Hospital Organization Okayama Medical Center Department of Pediatrics

junshimi@okayama3.hosp.go.jp086-294-9911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026